Open AccessEfficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria
Author(s) -
DeZhen Guo,
Jianwen Cheng,
Jiayan Yan,
Ao Huang,
Yupeng Wang,
Shiyu Zhang,
Ya Cao,
Xiaowu Huang,
Jia Fan,
Jian Zhou,
XinRong Yang
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-1353
Subject(s) - lenvatinib , medicine , milan criteria , hepatocellular carcinoma , hazard ratio , liver transplantation , oncology , adjuvant , cumulative incidence , confidence interval , gastroenterology , transplantation , sorafenib
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom